Immune cell-derived c3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin.
about
Complement regulation of T-cell alloimmunityThe CD39-adenosinergic axis in the pathogenesis of immune and nonimmune diabetesComplement regulation of T cell immunityPrognostic biomarkers in ovarian cancer.Immune cell-derived C3a and C5a costimulate human T cell alloimmunity.Resistance to Streptozotocin-Induced Autoimmune Diabetes in Absence of Complement C3: Myeloid-Derived Suppressor Cells Play a Role.Complement regulation of T-cell alloimmunity.Blocking type I interferon signaling rescues lymphocytes from oxidative stress, exhaustion, and apoptosis in a streptozotocin-induced mouse model of type I diabetes.Targeting regulatory T cells in the treatment of type 1 diabetes mellitus.Complement component 3 deficiency prolongs MHC-II disparate skin allograft survival by increasing the CD4(+) CD25(+) regulatory T cells population.The role of the complement system in metabolic organs and metabolic diseases.Protective Role of Complement C3 Against Cytokine-Mediated β-Cell Apoptosis.TLR-Induced Murine Dendritic Cell (DC) Activation Requires DC-Intrinsic Complement.The protective effects of CD39 overexpression in multiple low-dose streptozotocin-induced diabetes in mice.Human Gingiva-Derived Mesenchymal Stem Cells Ameliorate Streptozoticin-induced T1DM in mice via Suppression of T effector cells and Up-regulating Treg Subsets.T Cell Expression of C5a Receptor 2 Augments Murine Regulatory T Cell (TREG) Generation and TREG-Dependent Cardiac Allograft Survival.Streptozotocin-Induced Diabetic Models in Mice and Rats.Expression of Complement Components and Regulators by Different Subtypes of Bone Marrow-Derived Macrophages
P2860
Q26823956-7E8D43FA-E98B-4152-A020-A94948688F7BQ26825668-5B7B0D02-EAE5-41A2-94C2-8F5906A7BF56Q26827470-9B0CBAFC-A34D-41B0-860E-F4FF60CFA065Q34086636-9E30D66A-FB5D-4586-BCD6-3E15B7D0243DQ34370940-CAF82C05-F1A4-4659-8AD4-36F906F1A51DQ34793522-693F6D84-DBC0-4435-BDD5-7BD82C7ED38DQ35151737-F42A2434-19B0-44F8-902F-BDCBC852B8FFQ36711831-DDB41FCC-76B6-4646-8A07-2CFDBEED8C4EQ37006155-A9F74DCB-9944-4716-B4DE-2B74161D148EQ37264666-4A743A23-61C8-41FF-8365-72A9DBB7FEDCQ38107674-39AA21C7-83DF-4895-B5EA-311B4527EF00Q38743233-7FDFB5B9-C1EF-466E-BCAC-274A66A09C75Q38766473-81E9D0B4-C100-4280-9AE0-37B9DEE2EFD4Q40946206-35081B0B-5BE1-4C07-94A3-56D6076DBB68Q45281719-B316473D-86B0-44C8-9276-5EFF2F097848Q50048578-E3B0B46C-3F67-40AF-BC16-B88AB8A10E1CQ53359503-D3A1EC9F-8F17-4D5C-8DC1-8E0EC4DDA336Q57278869-047C1D9F-4553-4898-9EE8-C49E8AF1B01E
P2860
Immune cell-derived c3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Immune cell-derived c3 is requ ...... e low doses of streptozotocin.
@ast
Immune cell-derived c3 is requ ...... e low doses of streptozotocin.
@en
Immune cell-derived c3 is requ ...... e low doses of streptozotocin.
@nl
type
label
Immune cell-derived c3 is requ ...... e low doses of streptozotocin.
@ast
Immune cell-derived c3 is requ ...... e low doses of streptozotocin.
@en
Immune cell-derived c3 is requ ...... e low doses of streptozotocin.
@nl
prefLabel
Immune cell-derived c3 is requ ...... e low doses of streptozotocin.
@ast
Immune cell-derived c3 is requ ...... e low doses of streptozotocin.
@en
Immune cell-derived c3 is requ ...... e low doses of streptozotocin.
@nl
P2093
P2860
P356
P1433
P1476
Immune cell-derived c3 is requ ...... e low doses of streptozotocin.
@en
P2093
Barbara Murphy
Bernd Schröppel
M Edward Medof
Marvin Lin
Peter S Heeger
P2860
P304
P356
10.2337/DB10-0044
P407
P577
2010-06-28T00:00:00Z